• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Summit Corp PLC

+ Add to Watchlist


0.098 EUR 0.001 1.01%

As of 02:08:13 ET on 04/24/2014.

Snapshot for Summit Corp PLC (UVF)

Open: 0.098 Day's Range: 0.098 - 0.098 Volume: 0
Previous Close: 0.099 52wk Range: 0.041 - 0.211 1-Yr Rtn: +113.04%

Stock Chart for UVF

No chart data available.
  • UVF:GR 0.098
  • 1M
  • 1Y
Interactive UVF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for UVF

Current P/E Ratio (ttm) -
Estimated P/E(01/2014) -
Relative P/E vs. DAX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (01/2014) -0.0120
Est. PEG Ratio -
Market Cap (M EUR) 80.48
Shares Outstanding (M) 821.23
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for UVF

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for UVF

Summit Corporation plc is a drug discovery and development Company targeting areas of high unmet medical need. The Company is advancing two clinical-stage programmes: Utrophin modulators for the treatment of all genetic forms of the fatal disease, Duchenne Muscular Dystrophy, and a novel antibiotic for the selective treatment of infections caused by C. difficile bacteria.

Glyn O EdwardsChief Executive OfficerRaymond J SpencerCFO/Secretary
David RoblinChief Medical Officer
More Company Profile & Key Executives for UVF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil